)
Metabolic Nordic (MBOLIC) investor relations material
Metabolic Nordic Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Focused on developing the 100 Days concept and enhancing the proprietary platform for improved customer experience and scalability.
Prepared marketing activities and partnerships for scaling in the autumn.
Sold the Twiik-branded business in Q1, significantly impacting revenue and results.
Entered a conditional agreement to acquire DR VITOS, including financing and a capital guarantee.
Financial highlights
Q2 net revenue: 457 KSEK, down 86% year-over-year (Q2 2023: 3,323 KSEK).
Q2 operating result: -1,593 KSEK (Q2 2023: -2,920 KSEK).
Q2 net result after tax: -1,879 KSEK (Q2 2023: -3,054 KSEK); EPS: -0.06 SEK (Q2 2023: -0.10 SEK).
H1 net revenue: 2,550 KSEK, down 63% year-over-year (H1 2023: 6,967 KSEK).
H1 net result after tax: -4,482 KSEK (H1 2023: -5,446 KSEK); EPS: -0.15 SEK (H1 2023: -0.19 SEK).
Outlook and guidance
Management sees the DR VITOS acquisition as a significant opportunity to achieve positive cash flow in the short term.
Focus remains on metabolic health and digital solutions for sustainable weight loss.
)
)
)
)
)
)
)
)